Results 291 to 300 of about 3,854,141 (349)
Some of the next articles are maybe not open access.
Psychiatric Services, 1984
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
R A, Dominguez, B J, Goldstein
openaire +2 more sources
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
R A, Dominguez, B J, Goldstein
openaire +2 more sources
Beta-blockers for hypertension
2007Two recent systematic reviews found first-line beta-blockers to be less effective in reducing the incidence of stroke and the combined endpoint of stroke, myocardial infarction, and death compared to all other antihypertensive drugs taken together. However, beta-blockers might be better or worse than a specific class of drugs for a particular outcome ...
C S, Wiysonge +6 more
openaire +2 more sources
Beta-blockers for hypertension
2012This review is an update of the Cochrane Review published in 2007, which assessed the role of beta-blockade as first-line therapy for hypertension.To quantify the effectiveness and safety of beta-blockers on morbidity and mortality endpoints in adults with hypertension.In December 2011 we searched the Cochrane Central Register of Controlled Trials ...
Charles Shey, Wiysonge +5 more
openaire +3 more sources
Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.
JACC. Heart failure, 2023BACKGROUND Although studies consistently show that beta-blockers reduce morbidity and mortality in patients with reduced ejection fraction (EF), data are inconsistent in patients with heart failure with mildly reduced ejection fraction (HFmrEF) and ...
S. Arnold +7 more
semanticscholar +1 more source
The American Journal of Cardiology, 1983
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +2 more sources
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +2 more sources
The American Journal of Cardiology, 2010
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +2 more sources
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +2 more sources
Journal of Clinical Pharmacy and Therapeutics, 1983
S, Hutchison, L M, Campbell
openaire +2 more sources
S, Hutchison, L M, Campbell
openaire +2 more sources
Journal of Clinical Pharmacy and Therapeutics, 1984
P E, Hall, M J, Kendall, S R, Smith
openaire +2 more sources
P E, Hall, M J, Kendall, S R, Smith
openaire +2 more sources